We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$220M
Cap. Flow
+$92.2M
Cap. Flow %
5.11%
Top 10 Hldgs %
23.35%
Holding
698
New
144
Increased
374
Reduced
112
Closed
60

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$23M
2
MDLZ icon
Mondelez International
MDLZ
+$11.8M
3
GIS icon
General Mills
GIS
+$11.6M
4
JNJ icon
Johnson & Johnson
JNJ
+$8.36M
5
CRM icon
Salesforce
CRM
+$5.1M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$23.4M
2
V icon
Visa
V
+$13.3M
3
ADSK icon
Autodesk
ADSK
+$10.2M
4
PEP icon
PepsiCo
PEP
+$9.62M
5
ORCL icon
Oracle
ORCL
+$6.9M

Sector Composition

Rank Sector Weight
1 Technology 16.28%
2 Healthcare 15.36%
3 Financials 15.12%
4 Consumer Discretionary 11.34%
5 Industrials 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGO icon
76
Broadcom
AVGO
$2.03T
$3.88M 0.22%
157,380
+8,500
+6% +$191K
PNC icon
77
PNC Financial Services
PNC
$99.6B
$3.72M 0.21%
+27,340
New +$3.89M
MS icon
78
Morgan Stanley
MS
$334B
$3.7M 0.21%
79,485
-9,490
-11% -$463K
DE icon
79
Deere & Co
DE
$166B
$3.69M 0.2%
+24,540
New +$3.52M
AGN
80
DELISTED
Allergan plc
AGN
$3.59M 0.2%
18,870
-755
-4% -$139K
INTC icon
81
Intel
INTC
$513B
$3.58M 0.2%
75,819
-130,680
-63% -$6.36M
EW icon
82
Edwards Lifesciences
EW
$51.4B
$3.58M 0.2%
61,614
+13,125
+27% +$642K
FISV
83
Fiserv Inc
FISV
$28B
$3.57M 0.2%
43,300
+8,700
+25% +$683K
MU icon
84
Micron Technology
MU
$992B
$3.48M 0.19%
76,850
-6,300
-8% -$318K
ITW icon
85
Illinois Tool Works
ITW
$84.6B
$3.45M 0.19%
+24,425
New +$3.44M
ORLY icon
86
O'Reilly Automotive
ORLY
$75.3B
$3.42M 0.19%
147,900
+92,250
+166% +$1.96M
BLK icon
87
Blackrock
BLK
$176B
$3.4M 0.19%
7,210
-475
-6% -$231K
INTU icon
88
Intuit
INTU
$89.7B
$3.37M 0.19%
14,812
+5,300
+56% +$1.14M
PSX icon
89
Phillips 66
PSX
$80.3B
$3.35M 0.19%
29,694
+13,625
+85% +$1.58M
VRTX icon
90
Vertex Pharmaceuticals
VRTX
$122B
$3.3M 0.18%
17,100
-275
-2% -$49K
EMR icon
91
Emerson Electric
EMR
$88B
$3.27M 0.18%
42,700
-750
-2% -$55.3K
FIS icon
92
Fidelity National Information Services
FIS
$22.1B
$3.24M 0.18%
29,727
+17,070
+135% +$1.84M
DFS
93
DELISTED
Discover Financial Services
DFS
$3.17M 0.18%
41,450
+10,550
+34% +$794K
ALGN icon
94
Align Technology
ALGN
$11.7B
$3.16M 0.18%
8,070
+2,100
+35% +$775K
AON icon
95
Aon
AON
$75.6B
$3.14M 0.17%
20,401
-55
-0.3% -$8.04K
KO icon
96
Coca-Cola
KO
$373B
$3.11M 0.17%
67,364
+7,610
+13% +$348K
CVS icon
97
CVS Health
CVS
$122B
$3.08M 0.17%
39,105
– –
COF icon
98
Capital One
COF
$134B
$3.06M 0.17%
32,270
-4,720
-13% -$459K
BSX icon
99
Boston Scientific
BSX
$71.2B
$3.06M 0.17%
79,425
-1,900
-2% -$66.4K
ZTS icon
100
Zoetis
ZTS
$31.9B
$3.06M 0.17%
33,375
+1,450
+5% +$129K
2 3
4
5 6

Similar funds

MF
MHI Funds Woodstock, New York $34.7M AUM 17.93% 1-Year Est. Return
AIM
Act II Management New York $33.8M AUM 8.86% 1-Year Est. Return
QCMA
Quad Capital Management Advisors New York $31.4M AUM 22.55% 1-Year Est. Return
SC
Salzman & Co Pittsford, New York $29.7M AUM 12.12% 1-Year Est. Return
BIM
Beach Investment Management West Conshohocken, Pennsylvania $28.8M AUM 11.57% 1-Year Est. Return
GP
Gresham Partners Chicago, Illinois $26.2M AUM 18.05% 1-Year Est. Return
GAM
GQ Asset Management New York City, New York $52.7M AUM 8.84% 1-Year Est. Return
SCM
Shoals Capital Management Arlington, Virginia $21.5M AUM 38.8% 1-Year Est. Return

Oakbrook Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Oakbrook Investments held 698 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oakbrook Investments deployed $92.2M of net new capital in Q3 2018, opening 144 new positions and adding to 374 existing holdings. Its largest new stake was Colgate-Palmolive: 345,909 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $23.4M trimmed.

  • Oakbrook Investments's largest Q3 2018 buy was Colgate-Palmolive: 345,909 shares worth $23.2M.
  • Oakbrook Investments added most to Mondelez International in Q3 2018, an estimated $11.8M increase.
  • Oakbrook Investments's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $23.4M.
  • Oakbrook Investments fully exited CSX Corp in Q3 2018, selling an estimated $3.83M.
  • Oakbrook Investments's ten largest holdings make up 23% of its $1.8B portfolio in Q3 2018.
  • Oakbrook Investments opened 144 new positions and closed 60 in Q3 2018.
  • Oakbrook Investments's portfolio value rose 14% quarter-over-quarter to $1.8B.

Based on Oakbrook Investments's 13F filing for Q3 2018, filed 18 Oct 2018.